Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients.

Drugs & aging

Fialová D, Desplenter F.
PMID: 27010820
Drugs Aging. 2016 Mar;33(3):163-7. doi: 10.1007/s40266-016-0361-6.

No abstract available.

Cite
Fialová D, Desplenter F. Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients. Drugs Aging. 2016;33(3):163-7doi: 10.1007/s40266-016-0361-6.
Fialová, D., & Desplenter, F. (2016). Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients. Drugs & aging, 33(3), 163-7. https://doi.org/10.1007/s40266-016-0361-6
Fialová, Daniela, and Desplenter, Franciska. "Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients." Drugs & aging vol. 33,3 (2016): 163-7. doi: https://doi.org/10.1007/s40266-016-0361-6
Fialová D, Desplenter F. Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients. Drugs Aging. 2016 Mar;33(3):163-7. doi: 10.1007/s40266-016-0361-6. PMID: 27010820.
Copy Download .nbib Format: NLM
Introduction.

Drugs & aging

[No authors listed]
PMID: 26987847
Drugs Aging. 2016 Mar;33(3):161. doi: 10.1007/s40266-016-0364-3.

No abstract available.

Cite
Introduction. Drugs Aging. 2016;33(3):161doi: 10.1007/s40266-016-0364-3.
(2016). Introduction. Drugs & aging, 33(3), 161. https://doi.org/10.1007/s40266-016-0364-3
"Introduction." Drugs & aging vol. 33,3 (2016): 161. doi: https://doi.org/10.1007/s40266-016-0364-3
Introduction. Drugs Aging. 2016 Mar;33(3):161. doi: 10.1007/s40266-016-0364-3. PMID: 26987847.
Copy Download .nbib Format: NLM
Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects.

Drugs & aging

Allegaert K.
PMID: 26747059
Drugs Aging. 2016 Feb;33(2):159-60. doi: 10.1007/s40266-015-0338-x.

No abstract available.

Cite
Allegaert K. Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects. Drugs Aging. 2016;33(2):159-60doi: 10.1007/s40266-015-0338-x.
Allegaert, K. (2016). Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects. Drugs & aging, 33(2), 159-60. https://doi.org/10.1007/s40266-015-0338-x
Allegaert, Karel. "Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects." Drugs & aging vol. 33,2 (2016): 159-60. doi: https://doi.org/10.1007/s40266-015-0338-x
Allegaert K. Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects. Drugs Aging. 2016 Feb;33(2):159-60. doi: 10.1007/s40266-015-0338-x. PMID: 26747059.
Copy Download .nbib Format: NLM
Epidemiology and management of diverticular disease of the colon.

Drugs & aging

Kang JY, Melville D, Maxwell JD.
PMID: 15012168
Drugs Aging. 2004;21(4):211-28. doi: 10.2165/00002512-200421040-00001.

Colonic diverticula are protrusions of the mucosa through the outer muscular layers, which are usually abnormally thickened, to form narrow necked pouches. Diverticular disease of the colon covers a wide clinical spectrum: from an incidental finding to symptomatic uncomplicated...

Cite
Kang JY, Melville D, Maxwell JD. Epidemiology and management of diverticular disease of the colon. Drugs Aging. 2004;21(4):211-28doi: 10.2165/00002512-200421040-00001.
Kang, J. Y., Melville, D., & Maxwell, J. D. (2004). Epidemiology and management of diverticular disease of the colon. Drugs & aging, 21(4), 211-28. https://doi.org/10.2165/00002512-200421040-00001
Kang, Jin-Yong, et al. "Epidemiology and management of diverticular disease of the colon." Drugs & aging vol. 21,4 (2004): 211-28. doi: https://doi.org/10.2165/00002512-200421040-00001
Kang JY, Melville D, Maxwell JD. Epidemiology and management of diverticular disease of the colon. Drugs Aging. 2004;21(4):211-28. doi: 10.2165/00002512-200421040-00001. PMID: 15012168.
Copy Download .nbib Format: NLM
Spotlight on memantine in moderate to severe Alzheimer's disease.

Drugs & aging

McKeage K.
PMID: 20104942
Drugs Aging. 2010 Feb 01;27(2):177-9. doi: 10.2165/11204670-000000000-00000.

Memantine (Axura, Ebixa, Namenda) is an uncompetitive, moderate-affinity NMDA receptor antagonist that is indicated for the treatment of moderate to severe Alzheimer's disease. In well designed trials in patients with moderate to severe Alzheimer's disease, oral memantine monotherapy improved...

Cite
McKeage K. Spotlight on memantine in moderate to severe Alzheimer's disease. Drugs Aging. 2010;27(2):177-9doi: 10.2165/11204670-000000000-00000.
McKeage, K. (2010). Spotlight on memantine in moderate to severe Alzheimer's disease. Drugs & aging, 27(2), 177-9. https://doi.org/10.2165/11204670-000000000-00000
McKeage, Kate. "Spotlight on memantine in moderate to severe Alzheimer's disease." Drugs & aging vol. 27,2 (2010): 177-9. doi: https://doi.org/10.2165/11204670-000000000-00000
McKeage K. Spotlight on memantine in moderate to severe Alzheimer's disease. Drugs Aging. 2010 Feb 01;27(2):177-9. doi: 10.2165/11204670-000000000-00000. PMID: 20104942.
Copy Download .nbib Format: NLM
Clinical inertia remains a problem.

Drugs & aging

Klein R, Branch WT.
PMID: 22117093
Drugs Aging. 2011 Dec 01;28(12):943-4. doi: 10.2165/11598370-000000000-00000.

No abstract available.

Cite
Klein R, Branch WT. Clinical inertia remains a problem. Drugs Aging. 2011;28(12):943-4doi: 10.2165/11598370-000000000-00000.
Klein, R., & Branch, W. T. (2011). Clinical inertia remains a problem. Drugs & aging, 28(12), 943-4. https://doi.org/10.2165/11598370-000000000-00000
Klein, Robin, and Branch, William T. "Clinical inertia remains a problem." Drugs & aging vol. 28,12 (2011): 943-4. doi: https://doi.org/10.2165/11598370-000000000-00000
Klein R, Branch WT. Clinical inertia remains a problem. Drugs Aging. 2011 Dec 01;28(12):943-4. doi: 10.2165/11598370-000000000-00000. PMID: 22117093.
Copy Download .nbib Format: NLM
The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly.

Drugs & aging

Pazan F, Weiss C, Wehling M.
PMID: 27166962
Drugs Aging. 2016 Jun;33(6):447-9. doi: 10.1007/s40266-016-0371-4.

No abstract available.

Cite
Pazan F, Weiss C, Wehling M. The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly. Drugs Aging. 2016;33(6):447-9doi: 10.1007/s40266-016-0371-4.
Pazan, F., Weiss, C., Wehling, M. (2016). The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly. Drugs & aging, 33(6), 447-9. https://doi.org/10.1007/s40266-016-0371-4
Pazan, Farhad, et al. "The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly." Drugs & aging vol. 33,6 (2016): 447-9. doi: https://doi.org/10.1007/s40266-016-0371-4
Pazan F, Weiss C, Wehling M. The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly. Drugs Aging. 2016 Jun;33(6):447-9. doi: 10.1007/s40266-016-0371-4. PMID: 27166962.
Copy Download .nbib Format: NLM
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms.

Drugs & aging

Reginster JY, Bruyère O, Conaghan PG, McAlindon T, Cooper C.
PMID: 31073919
Drugs Aging. 2019 Apr;36:3-6. doi: 10.1007/s40266-019-00659-8.

No abstract available.

Cite
Reginster JY, Bruyère O, Conaghan PG, et al. Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs Aging. 2019;36:3-6doi: 10.1007/s40266-019-00659-8.
Reginster, J. Y., Bruyère, O., Conaghan, P. G., McAlindon, T., & Cooper, C. (2019). Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs & aging, 363-6. https://doi.org/10.1007/s40266-019-00659-8
Reginster, Jean-Yves, et al. "Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms." Drugs & aging vol. 36 (2019): 3-6. doi: https://doi.org/10.1007/s40266-019-00659-8
Reginster JY, Bruyère O, Conaghan PG, McAlindon T, Cooper C. Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms. Drugs Aging. 2019 Apr;36:3-6. doi: 10.1007/s40266-019-00659-8. PMID: 31073919; PMCID: PMC6509090.
Copy Download .nbib Format: NLM
Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People.

Drugs & aging

Pazan F, Weiss C, Wehling M.
PMID: 29968139
Drugs Aging. 2018 Jul;35(7):677. doi: 10.1007/s40266-018-0565-z.

In the original publication of this article, the members of the FORTA group were provided in such a way that they could not be indexed as collaborators on PubMed. The article should have included an Acknowledgement section as shown...

Cite
Pazan F, Weiss C, Wehling M. Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging. 2018;35(7):677doi: 10.1007/s40266-018-0565-z.
Pazan, F., Weiss, C., Wehling, M. (2018). Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs & aging, 35(7), 677. https://doi.org/10.1007/s40266-018-0565-z
Pazan, Farhad, et al. "Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People." Drugs & aging vol. 35,7 (2018): 677. doi: https://doi.org/10.1007/s40266-018-0565-z
Pazan F, Weiss C, Wehling M. Correction to: The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging. 2018 Jul;35(7):677. doi: 10.1007/s40266-018-0565-z. PMID: 29968139.
Copy Download .nbib Format: NLM
Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis.

Drugs & aging

van der Heijden LT, Mian P, Hias J, de Winter BCM, Tournoy J, Van der Linden L, Tibboel D, Walgraeve K, Flamaing J, Koch BCP, Allegaert K, Spriet I.
PMID: 34918212
Drugs Aging. 2022 Jan;39(1):83-95. doi: 10.1007/s40266-021-00912-z. Epub 2021 Dec 17.

INTRODUCTION: Paracetamol pharmacokinetics (PK) is highly variable in older fit adults after intravenous administration. Frailty and oral administration likely result in additional variability. The aim was to determine oral paracetamol PK and variability in geriatric inpatients.METHODS: A population PK...

Cite
van der Heijden LT, Mian P, Hias J, et al. Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis. Drugs Aging. 2021;39(1):83-95doi: 10.1007/s40266-021-00912-z.
van der Heijden, L. T., Mian, P., Hias, J., de Winter, B. C. M., Tournoy, J., Van der Linden, L., Tibboel, D., Walgraeve, K., Flamaing, J., Koch, B. C. P., Allegaert, K., & Spriet, I. (2022). Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis. Drugs & aging, 39(1), 83-95. https://doi.org/10.1007/s40266-021-00912-z
van der Heijden, L T, et al. "Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis." Drugs & aging vol. 39,1 (2022): 83-95. doi: https://doi.org/10.1007/s40266-021-00912-z
van der Heijden LT, Mian P, Hias J, de Winter BCM, Tournoy J, Van der Linden L, Tibboel D, Walgraeve K, Flamaing J, Koch BCP, Allegaert K, Spriet I. Highly Variable Paracetamol Pharmacokinetics After Multiple Oral Dosing in Frail Older People: A Population Pharmacokinetic Analysis. Drugs Aging. 2022 Jan;39(1):83-95. doi: 10.1007/s40266-021-00912-z. Epub 2021 Dec 17. PMID: 34918212.
Copy Download .nbib Format: NLM
Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder.

Drugs & aging

Gustafsson M, Lövheim H, Sjölander M.
PMID: 34664213
Drugs Aging. 2021 Nov;38(11):1017-1023. doi: 10.1007/s40266-021-00897-9. Epub 2021 Oct 19.

BACKGROUND AND OBJECTIVE: Pain is highly prevalent among older people, and treatment is complicated because of comorbidities and polypharmacy. Among people with major neurocognitive disorder additional difficulties might arise. The aim of this study was to describe analgesic drug...

Cite
Gustafsson M, Lövheim H, Sjölander M. Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder. Drugs Aging. 2021;38(11):1017-1023doi: 10.1007/s40266-021-00897-9.
Gustafsson, M., Lövheim, H., & Sjölander, M. (2021). Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder. Drugs & aging, 38(11), 1017-1023. https://doi.org/10.1007/s40266-021-00897-9
Gustafsson, Maria, et al. "Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder." Drugs & aging vol. 38,11 (2021): 1017-1023. doi: https://doi.org/10.1007/s40266-021-00897-9
Gustafsson M, Lövheim H, Sjölander M. Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder. Drugs Aging. 2021 Nov;38(11):1017-1023. doi: 10.1007/s40266-021-00897-9. Epub 2021 Oct 19. PMID: 34664213; PMCID: PMC8593018.
Copy Download .nbib Format: NLM
Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity.

Drugs & aging

Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, Spruit MR, Jungo KT, Rodondi N, Dalleur O, Spinewine A, Jennings E, O'Mahony D, Wilting I, Knol W.
PMID: 34877629
Drugs Aging. 2021 Dec 08; doi: 10.1007/s40266-021-00904-z. Epub 2021 Dec 08.

BACKGROUND: The Screening Tool of Older Persons' Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into software algorithms and implemented in...

Cite
Sallevelt BTGM, Huibers CJA, Heij JMJO, et al. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs Aging. 2021;doi: 10.1007/s40266-021-00904-z.
Sallevelt, B. T. G. M., Huibers, C. J. A., Heij, J. M. J. O., Egberts, T. C. G., van Puijenbroek, E. P., Shen, Z., Spruit, M. R., Jungo, K. T., Rodondi, N., Dalleur, O., Spinewine, A., Jennings, E., O'Mahony, D., Wilting, I., & Knol, W. (2021). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & aging, . https://doi.org/10.1007/s40266-021-00904-z
Sallevelt, Bastiaan T G M, et al. "Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity." Drugs & aging vol. (2021). doi: https://doi.org/10.1007/s40266-021-00904-z
Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, Spruit MR, Jungo KT, Rodondi N, Dalleur O, Spinewine A, Jennings E, O'Mahony D, Wilting I, Knol W. Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs Aging. 2021 Dec 08; doi: 10.1007/s40266-021-00904-z. Epub 2021 Dec 08. PMID: 34877629.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries